{
    "clinical_study": {
        "@rank": "52011", 
        "acronym": "ReActiv8-A", 
        "arm_group": {
            "arm_group_label": "ReActiv8 Implant", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this Clinical Study is to investigate the effect of electrical stimulation\n      for chronic low back pain."
        }, 
        "brief_title": "ReActiv8 for Chronic Low Back Pain", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Low Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age \u2265 21 years, \u226465 years\n\n          2. Chronic Low Back Pain with a first occurrence >90 days prior to enrolment, and the\n             last relatively pain-free time >90 days prior to enrolment.\n\n          3. Continuing low back pain despite >90 days of medical management\n\n          4. Oswestry Disability Index score \u226525% and \u226460% at the time of enrolment\n\n          5. Able to understand and sign the Informed Consent form.\n\n          6. Ability to comply with the instructions for use and to operate the ReActiv8, and to\n             comply with this Clinical Investigation Plan.\n\n          7. Suitable for ReActiv8 surgery as determined by the implanting physician prior to\n             inclusion.\n\n          8. Prior week average Low Back Pain NRS of \u22656.0 and \u22649.0 on a 11 point NRS scale (0-10)\n             at the Baseline Visit\n\n        Exclusion Criteria:\n\n          1. BMI > 35\n\n          2. Back Pain characteristics:\n\n               1. Scoliosis correction procedure at any time, or clinical diagnosis of scoliosis\n                  at any time.\n\n               2. Lumbar spine stenosis, as defined by an anterior-posterior diameter of the\n                  spinal canal of <10mm in subjects with lower extremity pain\n\n               3. Neurological deficit possibly associated with the back pain (e.g. foot drop).\n\n               4. Back pain due to pelvic or visceral reasons (e.g.: endometriosis or fibroids) or\n                  infection (e.g.: post herpetic neuralgia).\n\n          3. Any current indication for back surgery according to local institutional guidelines,\n             or has indication for back surgery but cannot undergo surgery for other reasons.\n\n          4. Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain)\n             below the knee.\n\n          5. Source of pain is the sacroiliac joint as determined by the Investigator.\n\n          6. Drug use\n\n          7. Surgical and other procedures exclusions\n\n          8. Any prior diagnosis of vertebral compression fracture, pars fracture, or annular tear\n             with disc protrusion\n\n          9. Any surgery (including elective surgery) planned in the twelve months following\n             consent.\n\n         10. Co-morbid chronic pain conditions\n\n         11. Other clinical conditions\n\n         12. Psycho-social exclusions\n\n         13. Protocol Compliance Exclusions\n\n         14. General exclusions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985230", 
            "org_study_id": "950002"
        }, 
        "intervention": {
            "arm_group_label": "ReActiv8 Implant", 
            "intervention_name": "ReActiv8 Implantable Stimulation System implanted and activated.", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 20, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Dominic Bailey", 
                    "phone": "(02) 4985 1860"
                }, 
                "facility": {
                    "address": {
                        "city": "Broadmeadow", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2292"
                    }, 
                    "name": "Hunter Clinical Research"
                }, 
                "investigator": {
                    "last_name": "Marc Russo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lise Mackie", 
                    "phone": "(7) 5447 2144"
                }, 
                "facility": {
                    "address": {
                        "city": "Noosa Heads", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4567"
                    }, 
                    "name": "Georgius Practice"
                }, 
                "investigator": {
                    "last_name": "Peter Georgius, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alison Meeking", 
                    "phone": "(3) 9595 6111"
                }, 
                "facility": {
                    "address": {
                        "city": "Caulfield South", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3162"
                    }, 
                    "name": "Metro Spinal Clinic"
                }, 
                "investigator": {
                    "last_name": "Bruce Mitchell, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "1", 
        "official_title": "Investigation of the ReActiv8 Implantable Stimulation System for Chronic Low Back Pain", 
        "other_outcome": {
            "measure": "Subject Global Impression of Change", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "overall_contact": {
            "email": "peter@mainstay-medical.com", 
            "last_name": "Peter Crosby", 
            "phone": "+353 1 897 0250"
        }, 
        "overall_official": {
            "affiliation": "Mainstay Medical", 
            "last_name": "Peter Crosby", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Australia: National Health and Medical Research Council (NHMRC)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "11 Point Numerical Rating Scale for Low Back Pain", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "measure": "Number of subjects with Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "90 days, 12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985230"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Oswestry Disability Index", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "source": "Mainstay Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mainstay Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}